JPH0724595B2 - サイトカインを製造する方法 - Google Patents
サイトカインを製造する方法Info
- Publication number
- JPH0724595B2 JPH0724595B2 JP1050209A JP5020989A JPH0724595B2 JP H0724595 B2 JPH0724595 B2 JP H0724595B2 JP 1050209 A JP1050209 A JP 1050209A JP 5020989 A JP5020989 A JP 5020989A JP H0724595 B2 JPH0724595 B2 JP H0724595B2
- Authority
- JP
- Japan
- Prior art keywords
- cytokine
- culture
- temperature
- value
- production
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000004127 Cytokines Human genes 0.000 title claims description 27
- 108090000695 Cytokines Proteins 0.000 title claims description 27
- 238000004519 manufacturing process Methods 0.000 title claims description 21
- 238000000034 method Methods 0.000 claims description 12
- 230000006698 induction Effects 0.000 claims description 9
- 239000000411 inducer Substances 0.000 claims description 7
- 230000016396 cytokine production Effects 0.000 claims description 6
- 210000004102 animal cell Anatomy 0.000 claims description 5
- 230000004071 biological effect Effects 0.000 claims description 3
- 230000001939 inductive effect Effects 0.000 claims description 2
- 210000000265 leukocyte Anatomy 0.000 description 12
- 239000000243 solution Substances 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 10
- 235000015097 nutrients Nutrition 0.000 description 8
- 102000000412 Annexin Human genes 0.000 description 6
- 108050008874 Annexin Proteins 0.000 description 6
- 108010002350 Interleukin-2 Proteins 0.000 description 6
- 102000000588 Interleukin-2 Human genes 0.000 description 6
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 230000000840 anti-viral effect Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 108010062580 Concanavalin A Proteins 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- 241000711408 Murine respirovirus Species 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 2
- 229960003957 dexamethasone Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000002555 ionophore Substances 0.000 description 2
- 230000000236 ionophoric effect Effects 0.000 description 2
- 238000010979 pH adjustment Methods 0.000 description 2
- PHEDXBVPIONUQT-RGYGYFBISA-N phorbol 13-acetate 12-myristate Chemical compound C([C@]1(O)C(=O)C(C)=C[C@H]1[C@@]1(O)[C@H](C)[C@H]2OC(=O)CCCCCCCCCCCCC)C(CO)=C[C@H]1[C@H]1[C@]2(OC(C)=O)C1(C)C PHEDXBVPIONUQT-RGYGYFBISA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000006992 Interferon-alpha Human genes 0.000 description 1
- 108010047761 Interferon-alpha Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 108090000978 Interleukin-4 Proteins 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108010089814 Plant Lectins Proteins 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229940088623 biologically active substance Drugs 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000009134 cell regulation Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000003226 mitogen Substances 0.000 description 1
- 150000004633 phorbol derivatives Chemical class 0.000 description 1
- 239000002644 phorbol ester Substances 0.000 description 1
- 239000003726 plant lectin Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011403 purification operation Methods 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 102000003390 tumor necrosis factor Human genes 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4721—Lipocortins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/57—IFN-gamma
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU2251-1049/88 | 1988-03-04 | ||
| HU881049A HU202594B (en) | 1988-03-04 | 1988-03-04 | Process for increasing yield of leucoquines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH01281095A JPH01281095A (ja) | 1989-11-13 |
| JPH0724595B2 true JPH0724595B2 (ja) | 1995-03-22 |
Family
ID=10952631
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1050209A Expired - Lifetime JPH0724595B2 (ja) | 1988-03-04 | 1989-03-03 | サイトカインを製造する方法 |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JPH0724595B2 (enrdf_load_stackoverflow) |
| CN (1) | CN1036794A (enrdf_load_stackoverflow) |
| AT (1) | AT392800B (enrdf_load_stackoverflow) |
| DE (1) | DE3907114A1 (enrdf_load_stackoverflow) |
| HU (1) | HU202594B (enrdf_load_stackoverflow) |
| IT (1) | IT1229193B (enrdf_load_stackoverflow) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2906160A1 (de) * | 1979-02-17 | 1980-09-04 | Thomae Gmbh Dr K | Verbessertes verfahren zur herstellung von humaninterferon |
| US4357422A (en) * | 1980-08-14 | 1982-11-02 | Massachusetts Institute Of Technology | Method of enhancing interferon production |
| JPS57105195A (en) * | 1980-10-24 | 1982-06-30 | Nat Res Dev | Production of interferon |
| JPS6296083A (ja) * | 1985-10-21 | 1987-05-02 | Toray Ind Inc | 動物細胞の培養方法 |
-
1988
- 1988-03-04 HU HU881049A patent/HU202594B/hu not_active IP Right Cessation
-
1989
- 1989-03-03 IT IT8919632A patent/IT1229193B/it active
- 1989-03-03 JP JP1050209A patent/JPH0724595B2/ja not_active Expired - Lifetime
- 1989-03-03 AT AT481/89A patent/AT392800B/de not_active IP Right Cessation
- 1989-03-03 CN CN89102021.7A patent/CN1036794A/zh active Pending
- 1989-03-06 DE DE3907114A patent/DE3907114A1/de active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| HUT50218A (en) | 1989-12-28 |
| IT8919632A0 (it) | 1989-03-03 |
| DE3907114A1 (de) | 1989-09-14 |
| AT392800B (de) | 1991-06-10 |
| JPH01281095A (ja) | 1989-11-13 |
| CN1036794A (zh) | 1989-11-01 |
| DE3907114C2 (enrdf_load_stackoverflow) | 1991-12-19 |
| IT1229193B (it) | 1991-07-25 |
| ATA48189A (de) | 1990-11-15 |
| HU202594B (en) | 1991-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4564593A (en) | Messenger RNA, production and use thereof | |
| US4376821A (en) | Production of human IFN-gamma (immune) interferon | |
| US4216203A (en) | Process for producing interferon | |
| US4357422A (en) | Method of enhancing interferon production | |
| EP0291728A2 (en) | Production of immune interferon and its mRNA | |
| US3800035A (en) | Production of interferon from human leukocytes in the absence of serum | |
| FI72143B (fi) | Foerfarande foer framstaellning av maenniskointerferon | |
| EP0017570B1 (en) | Process for the preparation of interferon and culture medium composition used in it | |
| US3122476A (en) | Tissue culture medium | |
| US4680261A (en) | Process for producing interferon | |
| EP0014050A2 (en) | Interferon production | |
| SU1713591A1 (ru) | Способ получени человеческого лейкоцитарного интерферона | |
| EP0097353B1 (en) | Improved process for interferon production | |
| DE69232259T2 (de) | Verfahren zur Herstellung von Interleukin-6 Zusammensetzungen | |
| JPH0724595B2 (ja) | サイトカインを製造する方法 | |
| US5468635A (en) | In vitro method for stimulating cell growth by culturing cells in a serum-free culture medium comprising human lysozyme | |
| US4452893A (en) | Cell growth medium supplement | |
| JPS58502032A (ja) | ヒトｒ−インタ−フェロンの製造方法 | |
| JP3147414B2 (ja) | インターロイキン−６の産生法 | |
| EP0498992A2 (en) | Serum-free culture medium containing lysozyme | |
| JP2566761B2 (ja) | 骨髄単球系細胞 | |
| JP3024430B2 (ja) | 生理活性物質の産生方法 | |
| EP0030094A1 (en) | Calcium enhanced interferon production process | |
| JPS6158594A (ja) | インタ−フエロン−αの製造方法 | |
| JP2002533112A (ja) | インターフェロンαの製造の改良 |